← Back to Search

Behavioural Intervention

Blood Flow Restriction Exercise for Multiple Sclerosis (BRAVe-MS Trial)

N/A
Recruiting
Led By Mark M Manago, PT
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PDDS 5: Late cane
PDDS 6: Bilateral support
Must not have
History of deep venous thrombosis/pulmonary embolism, peripheral vascular disease, thrombophilia, clotting disorders
PDDS 3 or less: MS does not interfere with activities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline (week 0) and primary endpoint (week 11)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of strength training using blood flow restriction in people with advanced disability due to MS. The goal is to help improve strength, mobility, fatigue, and quality of life.

Who is the study for?
This trial is for Veterans aged 18-75 with a confirmed MS diagnosis who need assistance to walk or use a wheelchair but can sit in one for over an hour. They should not have severe cognitive issues, recent blood clots, extremely high blood pressure, intense leg muscle stiffness, or be on certain MS treatments.
What is being tested?
The study tests a strength training program using Blood Flow Restriction (BFR) designed for those with advanced disability from MS. BFR partially blocks blood flow during exercise, simulating high-intensity workouts at lower intensities which may improve strength and quality of life.
What are the potential side effects?
Potential side effects might include discomfort from the pressure cuff used to restrict blood flow and possible bruising. Since it's low intensity exercise, other risks are likely minimal but could include typical exercise-related strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need a cane to walk because of my condition.
Select...
I need help to walk.
Select...
I have been diagnosed with multiple sclerosis.
Select...
I am between 18 and 75 years old.
Select...
I need a cane to walk because of my condition.
Select...
I use a wheelchair or scooter for mobility.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of blood clots or clotting disorders.
Select...
My MS allows me to do daily activities without help.
Select...
I have other health conditions or pain that affect my physical abilities.
Select...
I cannot do a seated leg press or fully straighten my knee against gravity in at least one leg.
Select...
I cannot sit in a wheelchair for more than an hour.
Select...
My legs are very stiff, scoring over 2 on a spasticity scale.
Select...
I bruise easily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline (week 0) and primary endpoint (week 11)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline (week 0) and primary endpoint (week 11) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Quadriceps muscle strength
Secondary study objectives
30-second sit to stand
Modified Fatigue Impact Scale
Muscle morphology
Other study objectives
Activity Monitor Sedentary Time
Berg Balance Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low-Load Exercise with Blood Flow RestrictionExperimental Treatment1 Intervention
The BFR intervention will combine low-load resistance training with between 60%-80% blood flow occlusion under the supervision of a licensed physical therapist.
Group II: Low-Load Exercise ControlActive Control1 Intervention
The control group with consist only of low-load resistance training under the supervision of a licensed physical therapist.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,725 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
1,133 Patients Enrolled for Multiple Sclerosis
Mark M Manago, PTPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO

Media Library

Low-Load Exercise with Blood Flow Restriction (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05433103 — N/A
Multiple Sclerosis Research Study Groups: Low-Load Exercise with Blood Flow Restriction, Low-Load Exercise Control
Multiple Sclerosis Clinical Trial 2023: Low-Load Exercise with Blood Flow Restriction Highlights & Side Effects. Trial Name: NCT05433103 — N/A
Low-Load Exercise with Blood Flow Restriction (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05433103 — N/A
~36 spots leftby Dec 2027